Benzinga | Nov 5, 2020 07:16AM EST

Aldeyra Therapeutics Q3 EPS $(0.23) Beats $(0.27) Estimate

Aldeyra Therapeutics (NASDAQ:ALDX) reported quarterly losses of $(0.23) per share which beat the analyst consensus estimate of $(0.27) by 14.81 percent. This is a 66.67 percent increase over losses of $(0.69) per share from the same period last year.